89BIO INC. - COMMON STOCK
10.57
14-February-25 15:45:00
15 minutes delayed
Stocks
-0.15
-1.40%
Today's range
10.43 - 11.01
ISIN
N/A
Source
NASDAQ
-
89bio Appoints Francis Sarena as Chief Operating Officer
07 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
89bio Reports Second Quarter 2024 Financial Results and Corporate Updates
05 Aug 2024 15:05:00 By Nasdaq GlobeNewswire
-
89bio Appoints Charles McWherter, Ph.D., to its Board of Directors
05 Aug 2024 07:00:00 By Nasdaq GlobeNewswire
-
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12 Jul 2024 15:05:00 By Nasdaq GlobeNewswire
-
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
14 Jun 2024 15:05:00 By Nasdaq GlobeNewswire
-
22 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
14 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
89bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
09 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
89bio to Participate in the BofA Securities 2024 Health Care Conference
08 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
89bio to Host Key Opinion Leader Webinar on Pegozafermin’s Opportunity in Advanced MASH
02 May 2024 15:05:00 By Nasdaq GlobeNewswire
-
89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
17 Apr 2024 15:05:00 By Nasdaq GlobeNewswire
-
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Apr 2024 15:05:00 By Nasdaq GlobeNewswire
-
27 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
12 Mar 2024 07:00:00 By Nasdaq GlobeNewswire
-
89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
08 Mar 2024 15:05:00 By Nasdaq GlobeNewswire
-
89bio to Participate in the Leerink Partners Global Biopharma Conference
05 Mar 2024 15:05:00 By Nasdaq GlobeNewswire
-
89bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
29 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
89bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
06 Feb 2024 15:05:00 By Nasdaq GlobeNewswire
-
89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05 Feb 2024 15:05:00 By Nasdaq GlobeNewswire